On 25 November 2019, the Latvian Competition Council (Council) published a report on “Medicines: Price formation and possible restrictions on competition affecting their financial availability”. The aim of the study was to consider the factors affecting prices and financial availability of medicines in Latvia. The study compared the regulatory frameworks of Latvia, Lithuania and Estonia […]
Publication / Marina Golovnitskaya, Kirill Laptev, Yauheni Budchanka, Pavel Lashuk,
1. Introduction The introduction should provide an overview of the relationship between pharma regulation and general privacy and data protection law. 1.1. Legislation Key acts, regulations, directives governing the health and pharma sector, and which are relevant to privacy and data protection The key legal act governing the health and pharma sector is the Law […]
Potential changes in Lithuanian pharmaceutical industry: state owned pharmacies are coming on to the market On 27 March 2019, the Lithuanian Cabinet of Ministers approved Resolution No XIIIP-1939 drafted by the Ministry of Health (in Lithuanian), which proposes expanding the functions of state owned health care institutions. The Government of Lithuania has approved an amendment […]
Amendments adopted to increase availability of medicines On 16 July 2019 Cabinet of Ministers Regulations No 899 of 31 October 2006 “Procedure for reimbursement of reimbursable medicines and medical devices” (in Latvian) was amended. The amendments (in Latvian) are claimed to be a major improvement in the availability of medicines, for example reducing patient co-payments […]
Estonia and Portugal agree to mutually recognise electronic prescriptions Estonia and Portugal signed an agreement on mutual recognition of electronic prescriptions by the end of 2019. The agreement was signed on 16 April 2019 by the Estonian minister of entrepreneurship and information technology and the Portuguese minister of health. Now both Estonia and Portugal will […]
